Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery

Blood Coagulation and Fibrinolysis - Tập 28 Số 4 - Trang 295-302 - 2017
Mariann Tang1,2,3,4,5,6,7, Per Wierup2, Catherine Rea3,4, Jørgen Ingerslev1,3,4, Vibeke E. Hjortdal2, Benny Sørensen1,3,4
1Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus, Denmark
2Department of Cardiothoracic and Vascular Surgery
3Haemostasis Research Unit, Centre for Haemostasis and Thrombosis, Guy's and St Thomas' NHS Foundation Trust
4King’s College London School of Medicine, London, UK
5e-mail: [email protected]
6fax: +45 78453075
7to Mariann Tang, MD, Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark Tel: +45 78453030

Tóm tắt

Từ khóa


Tài liệu tham khảo

Dacey, 1998, Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group, Arch Surg, 133, 442, 10.1001/archsurg.133.4.442

Hall, 2002, Hemorrhage related reexploration following open heart surgery: the impact of preoperative and postoperative coagulation testing, Cardiovasc Surg, 10, 146, 10.1016/S0967-2109(01)00129-6

Karthik, 2004, Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay, Ann Thorac Surg, 78, 527, 10.1016/j.athoracsur.2004.02.088

Ranucci, 2008, Surgical reexploration after cardiac operations: why a worse outcome?, Ann Thorac Surg, 86, 1557, 10.1016/j.athoracsur.2008.07.114

Litmathe, 2009, Predictors and outcome of ICU readmission after cardiac surgery, Thorac Cardiovasc Surg, 57, 391, 10.1055/s-0029-1185852

Jimenez Rivera, 2007, Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study, J Cardiothorac Surg, 2, 17, 10.1186/1749-8090-2-17

Ray, 1994, Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass, Blood Coagul Fibrinolysis, 5, 679, 10.1097/00001721-199410000-00002

Khuri, 1995, Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass, Ann Thorac Surg, 60, 1008, 10.1016/0003-4975(95)00668-B

Blome, 2005, Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery, Thromb Haemost, 93, 1101, 10.1160/TH04-12-0799

Brown, 2007, Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery, Circulation, 115, 2801, 10.1161/CIRCULATIONAHA.106.671222

Murkin, 2010, High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients, Anesth Analg, 110, 350, 10.1213/ANE.0b013e3181c92b23

Fergusson, 2008, A comparison of aprotinin and lysine analogues in high-risk cardiac surgery, N Engl J Med, 358, 2319, 10.1056/NEJMoa0802395

Dowd, 2002, Pharmacokinetics of tranexamic acid during cardiopulmonary bypass, Anesthesiology, 97, 390, 10.1097/00000542-200208000-00016

Horrow, 1995, The dose-response relationship of tranexamic acid, Anesthesiology, 82, 383, 10.1097/00000542-199502000-00009

Karkouti, 2010, The influence of perioperative coagulation status on postoperative blood loss in complex cardiac surgery: a prospective observational study, Anesth Analg, 110, 1533, 10.1213/ANE.0b013e3181db7991

Chandler, 2004, Plasmin generation and D-dimer formation during cardiopulmonary bypass, Blood Coagul Fibrinolysis, 15, 583

Chandler, 1995, Individual variations in the fibrinolytic response during and after cardiopulmonary bypass, Thromb Haemost, 74, 1293, 10.1055/s-0038-1649929

Cannon, 1975, Improved method for euglobulin clot lysis time, Clin Biochem, 8, 206, 10.1016/S0009-9120(75)92077-9

Kupesiz, 2010, Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography, Blood Coagul Fibrinolysis, 21, 320, 10.1097/MBC.0b013e32833464e9

Smith, 2003, A new euglobulin clot lysis assay for global fibrinolysis, Thromb Res, 112, 329, 10.1016/j.thromres.2004.01.001

Chitlur, 2012, Challenges in the laboratory analyses of bleeding disorders, Thromb Res, 130, 1, 10.1016/j.thromres.2012.03.011

Bellomo, 2004, Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, R204, 10.1186/cc2872

Rea, 2012, Factor XIII in the treatment of hemophilia A, N Engl J Med, 366, 281, 10.1056/NEJMc1113270

Sorensen, 2003, Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation, J Thromb Haemost, 1, 551, 10.1046/j.1538-7836.2003.00075.x

Karlsson, 2008, Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study, Transfusion, 48, 2152, 10.1111/j.1537-2995.2008.01827.x

Solomon, 2011, Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery, Thromb Res, 128, 277, 10.1016/j.thromres.2011.02.022

Rea, 2011, Fibrinogen: a procoagulant and an anticoagulant, Blood (ASH Annual Meeting Abstracts, 116, 384

Grassin-Delyle, 2013, Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass, Br J Anaesth, 111, 916, 10.1093/bja/aet255

Kalavrouziotis, 2012, High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass, Ann Thorac Surg, 93, 148, 10.1016/j.athoracsur.2011.07.085

Rea, 2011, Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A, J Thromb Haemost, 9, 510, 10.1111/j.1538-7836.2010.04171.x

Ostrowski, 2011, Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study, Scand J Trauma Resusc Emerg Med, 19, 64, 10.1186/1757-7241-19-64

Larsen, 2012, Improved point-of-care identification of hyperfibrinolysis is needed, Thromb Res, 130, 690, 10.1016/j.thromres.2012.08.291

Pommerening, 2014, Early diagnosis of clinically significant hyperfibrinolysis using thrombelastography velocity curves, J Am Coll Surg, 219, 1157, 10.1016/j.jamcollsurg.2014.07.943

Dirkmann, 2014, Assessment of early thromboelastometric variables from extrinsically activated assays with and without aprotinin for rapid detection of fibrinolysis, Anesth Analg, 119, 533, 10.1213/ANE.0000000000000333

Natorska, 2010, Fibrin presence within aortic valves in patients with aortic stenosis: association with in vivo thrombin generation and fibrin clot properties, Thromb Haemost, 105, 254, 10.1160/TH10-09-0612

Jankun, 2007, Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis, Int J Mol Med, 20, 683

Ferraris, 2011, 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines, Ann Thorac Surg, 91, 944, 10.1016/j.athoracsur.2010.11.078

Young, 2013, Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state-of-art and future perspectives, Blood, 121, 1944, 10.1182/blood-2012-08-378935